DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / LB Pharmaceuticals Inc
LB Pharmaceuticals Inc
Stage unknownNew York, NYPharmaceuticals
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Aug 29, 2023Form D equity offering · $111M (form d sold) · 6 investorsFact SEC EDGAR Form D data sets (quarterly) · “LB Pharmaceuticals Inc filed Form D/A: $110,730,354 sold of $110,730,354, Pharmaceuticals”
Investors on record
1 edges
- Vida Ventures Management board only, Rajul Jain (strongly supported) Inference sec.gov
People
4 officers, 6 directors
- Andrew Vaino Executive Officer sec.gov
- Anna Eramo Executive Officer sec.gov
- Marc Panoff Executive Officer sec.gov
- Zachary Prensky Executive Officer/Director sec.gov
- Robert Ruffolo Director Fact
- Rebecca Luse Director Fact
- Chen Yu Director Fact
- Rajul Jain Director Fact
- Rajul Jain Director Inference
- RAN Nussbaum Director Fact
Timeline
1
- Jan 10, 2024LB Pharmaceuticals Inc filed Form D/A: $110,730,354 sold of $110,730,354, PharmaceuticalsForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company
- Entity type: Corporation Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Pharmaceuticals Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: true Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $111M Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $111M Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2023-08-29 Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 6 Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity,option Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 575 MADISON AVENUE, NEW YORK, NY, 10022 Jan 10, 2024 Fact SEC EDGAR Form D data sets (quarterly)